Evidence map›Paper›PMID 17875350›Full record

ArticleVaccine2007

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Joan E Smallshaw, James A Richardson, Ellen S Vitetta

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. The Search for Antidotes Against Ricin.Mini reviews in medicinal chemistry · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joan E SmallshawThe Cancer Immunobiology Center and the Department of Microbiology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8576, USA.
James A Richardson
Ellen S Vitetta
The University of Texas Southwestern Medical Center · US

Funding

A Novel Recombinant Protein Vaccine Against Ricin ToxinU01AI056372 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI VITETTA, ELLEN S · 2003 to 2006
$2.6M
NIAID NIH HHS AI-056372NIAID NIH HHS U01 AI056372
6 · The paper itself

Abstract

Ricin is a plant toxin that is a CDC level B biothreat. Our recombinant ricin A chain vaccine (RiVax), which contains mutations in both known toxic sites, has no residual toxicity at doses at least 800 times the immunogenic dose. RiVax without adjuvant given intramuscularly (i.m.) protected mice against intraperitoneally administered ricin. Furthermore the vaccine without alum was safe and immunogenic in human volunteers. Here we describe the development of gavage and aerosol ricin challenge models in mice and demonstrate that i.m. vaccination protects mice against ricin delivered by either route. Also RiVax protects against aerosol-induced lung damage as determined by histology and lung function tests.

Indexed as

Administration, InhalationAdministration, OralAerosolsAnimalsBioterrorismGenes, PlantHumansInjections, IntramuscularIntestinesLethal Dose 50LungMiceMutationPlants, ToxicRicinRicinusAerosolsRicinRiVaxVaccinesVaccines, Synthetic

Identifiers

PMID17875350
PMCPMC2049008
OpenAlexW2038620985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.